Roche withdraws Tecentriq U.S. indication for prior-platinum treated metastatic urothelial carcinoma March 8, 2021
Abivax stops phase IIb/III trial of ABX-464 in high-risk COVID-19 based on DSMB recommendation March 8, 2021
FDA grants accelerated approval to Yescarta for relapsed or refractory follicular lymphoma March 8, 2021